✦ LIBER ✦

Screening for urinary bladder cancer with the use of nuclear matrix protein (NMP) 22: is it feasible?

✍ Scribed by Stefanopoulos, Anastasios; Economopoulos, Konstantinos P

Book ID: 125401503
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 119 KB
Volume: 12
Category: Article
ISSN: 1617-9625
DOI: 10.1186/1617-9625-12-S1-A6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Could nuclear matrix protein 22 (NMP22)

Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer? – experience at Kuwait University

✍ K. Kapila; E. O. Kehinde; J. T. Anim; O. A. Mojiminiyi; A. Vinsu; S. S. George; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Evaluation of a urinary assay for nuclea

Evaluation of a urinary assay for nuclear matrix protein (NMP22). A marker for transitional cell carcinoma of the bladder

✍ D.A Gornall; A Toguri 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Urinary nuclear matrix protein 22 (NMP22

Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder

✍ Jonathan H. Hughes; Ruth L. Katz; Julio Rodriguez-Villanueva; Larry Kidd; Colin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 1 views

This study compares urine nuclear matrix protein 22 (NMP22) immunoassay and conventional urine cytologic examination for detecting recurrent transitional-cell carcinoma (TCC) of the urinary bladder. One hundred twenty-eight urine specimens from 107 patients with a history of TCC of the urinary bladd

The clinical utility of atypical cytolog

The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22

✍ Rupesh Raina; Geetu Pahlajani; Lee E. Ponsky; Ashok Agarwal; Craig D. Zippe 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

URINARY LEVEL OF NUCLEAR MATRIX PROTEIN

URINARY LEVEL OF NUCLEAR MATRIX PROTEIN 22 IN THE DIAGNOSIS OF BLADDER CANCER: : EXPERIENCE WITH 130 PATIENTS WITH BIOPSY CONFIRMED TUMOR

✍ CASELLA, ROBERTO; HUBER, PETER; BLÖCHLINGER, ANDREA; STOFFEL, FLAVIO; DALQUEN, P 📂 Article 📅 2000 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB

POD-09.04: A comparison of specificity o

POD-09.04: A comparison of specificity of urine cytology, urinary nuclear matrix protein 22 [NMP22] and multi-target fluorescent in situ hybridization [FISH] assay in bladder cancer patients with no recurrence at surveillance

✍ E.O. Kehinde; F. Al-Mulla; S. Jacob; K. Kapila; J.T. Anim; V. Jerin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 84 KB